A Single Ascending Dose Trial of CVL-936 in Healthy Subjects

NCT04232878 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped Sufficient data has been obtained to meet current objectives

Conditions

Substance Use Disorders (SUD)

Interventions

DRUG: CVL-936
DRUG: Matching Placebo

Sponsor

Cerevel Therapeutics, LLC